Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments

Latus, Joerg; Klein, Reinhild; Koetter, Ina; Schwab, Matthias; Fritz, Peter; Kimmel, Martin; Alscher, M. Dominik; Braun, Niko

dc.contributor.author	Klein, Reinhild
dc.contributor.author	Schwab, Matthias
dc.date.accessioned	2014-02-04T10:25:52Z
dc.date.available	2014-02-04T10:25:52Z
dc.date.issued	2013
dc.identifier.issn	1932-6203
dc.identifier.uri	http://hdl.handle.net/10900/40554
dc.language.iso	en	en
dc.publisher	Public Library Science	de_DE
dc.relation.uri	http://dx.doi.org/10.1371/journal.pone.0078856	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	500	de_DE
dc.title	Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140116051827_00199	de_DE
utue.personen.roh	Latus, Joerg
utue.personen.roh	Klein, Reinhild
utue.personen.roh	Koetter, Ina
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Fritz, Peter
utue.personen.roh	Kimmel, Martin
utue.personen.roh	Alscher, M. Dominik
utue.personen.roh	Braun, Niko
dcterms.isPartOf.ZSTitelID	Plos One	de_DE
dcterms.isPartOf.ZS-Issue	Article e78856	de_DE
dcterms.isPartOf.ZS-Volume	8	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE